ET-traps Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $100K
Latest Deal Amount
  • Investors
  • 2

ET-traps General Information

Description

Developer of endothelin-1 traps. The company develops endothelin-1 traps which are antibody-based fusion proteins that could bind and sequester the increased levels of endothelin-1 found in different diseases.

Contact Information

Formerly Known As
EndoTraps
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Primary Office
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ET-traps Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator $100K 00000 Completed Startup
1. Accelerator/Incubator 12-Apr-2015 Completed Startup
To view ET-traps’s complete valuation and funding history, request access »

ET-traps Executive Team (1)

Name Title Board Seat Contact Info
Helene Fox Co-Founder
To view ET-traps’s complete executive team members history, request access »

ET-traps Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accelerate Cambridge Accelerator/Incubator Minority 000 0000 000000 0
Founder.org Accelerator/Incubator Minority 000 0000 000000 0
To view ET-traps’s complete investors history, request access »